← All companies

MAZE

Maze Therapeutics, Inc.

MAZE Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$27.61

+0.28 +1.02%

Key statistics

from XBRL data in SEC filings

Market cap

$1.53B

Revenue (TTM)

$168M

Net income (TTM)

-$123M

EPS (TTM)

$-2.35

P/E ratio

—

Dividend yield

—

Free cash flow

-$113M

Cash

$199M

Total assets

$420M

Gross margin

—

52-week range

$12.81 – $53.65

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 10, 2026 8-K Director or officer change May 22, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Other events Apr 22, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Mar 25, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Feb 4, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Director or officer change Oct 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Sep 11, 2025 8-K Director or officer change Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025

Other filings

144 Aug 3, 2026 4 Jul 31, 2026 144 Jul 29, 2026 SCHEDULE 13G Jul 29, 2026 4 Jul 2, 2026 4 Jul 2, 2026 144 Jul 1, 2026 4 Jul 1, 2026 144 Jul 1, 2026 4 Jun 24, 2026 4 Jun 10, 2026 4 Jun 10, 2026 4 Jun 10, 2026 4 Jun 10, 2026 4 Jun 10, 2026 4 Jun 10, 2026 4 Jun 3, 2026 4 Jun 3, 2026 4 Jun 2, 2026 144 Jun 1, 2026 4 May 27, 2026